These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31436505)

  • 41. Sensitizing pathogens to antibiotics using the CRISPR-Cas system.
    Goren M; Yosef I; Qimron U
    Drug Resist Updat; 2017 Jan; 30():1-6. PubMed ID: 28363331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Too Much Compromise in Today's CRISPR Pipelines.
    Fox R
    CRISPR J; 2019 Jun; 2(3):143-145. PubMed ID: 31225751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome editing: CRISPR-Cas becoming more human.
    Baumann K
    Nat Rev Mol Cell Biol; 2017 Oct; 18(10):591. PubMed ID: 28811667
    [No Abstract]   [Full Text] [Related]  

  • 44. CRISPR-Cas in its prime.
    Zlotorynski E
    Nat Rev Mol Cell Biol; 2019 Dec; 20(12):718-719. PubMed ID: 31685954
    [No Abstract]   [Full Text] [Related]  

  • 45. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.
    Gholizadeh P; Aghazadeh M; Asgharzadeh M; Kafil HS
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2043-2051. PubMed ID: 28601970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation of an integrated antibiotic resistance gene in mammalian cells to re-enable antibiotic selection.
    Ni P; Zhang Q; Chen H; Chen L
    Biotechniques; 2014; 56(4):198-201. PubMed ID: 24724846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL
    Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A decade of discovery: CRISPR functions and applications.
    Barrangou R; Horvath P
    Nat Microbiol; 2017 Jun; 2():17092. PubMed ID: 28581505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current and future prospects for CRISPR-based tools in bacteria.
    Luo ML; Leenay RT; Beisel CL
    Biotechnol Bioeng; 2016 May; 113(5):930-43. PubMed ID: 26460902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
    Meng X; Zhou H; Xu S
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRISPR inhibitors.
    Rusk N
    Nat Methods; 2019 Jul; 16(7):577. PubMed ID: 31249419
    [No Abstract]   [Full Text] [Related]  

  • 53. Applications of CRISPR systems in respiratory health: Entering a new 'red pen' era in genome editing.
    Moses C; Kaur P
    Respirology; 2019 Jul; 24(7):628-637. PubMed ID: 30883991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
    Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
    Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Challenges and advances of CRISPR-Cas9 genome editing in therapeutics.
    Stellos K; Musunuru K
    Cardiovasc Res; 2019 Feb; 115(2):e12-e14. PubMed ID: 30668679
    [No Abstract]   [Full Text] [Related]  

  • 56. Genetic engineering: Chemical control for CRISPR editing.
    Hilton IB; Gersbach CA
    Nat Chem Biol; 2017 Jan; 13(1):2-3. PubMed ID: 27820804
    [No Abstract]   [Full Text] [Related]  

  • 57. Expanding the Scope of CRISPR/Cpf1-Mediated Genome Editing in Rice.
    Li S; Zhang X; Wang W; Guo X; Wu Z; Du W; Zhao Y; Xia L
    Mol Plant; 2018 Jul; 11(7):995-998. PubMed ID: 29567453
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibiting CRISPR.
    Rusk N
    Nat Methods; 2019 Mar; 16(3):218. PubMed ID: 30814697
    [No Abstract]   [Full Text] [Related]  

  • 59. Editing the microbiome the CRISPR way.
    Ramachandran G; Bikard D
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180103. PubMed ID: 30905295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Include egg donors in CRISPR gene-editing debate.
    Niemiec E; Howard HC
    Nature; 2019 Nov; 575(7781):51. PubMed ID: 31690864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.